U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07313371) titled 'Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine/Crack Use Disorder' on Dec. 02, 2025.
Brief Summary: This is a single-center, randomized intervention study in a volunteer population of patients with cocaine/crack use disorder to evaluate the pharmacological treatment of cocaine/crack craving, comparing the drug clonidine with the active placebo clonazepam.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Cocaine Use Disorder
Crack Abuse or Dependence
Intervention:
DRUG: clonidine
Clonidine 0,1 mg bid
DRUG: clonazepam 0,25 mg
clonazepam 0,25 mg bid
Recruitment Status: NOT_YET_RECRUITING...